Related Experiment Video
Updated: May 30, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Advances in pancreatic cancer
Edward J Kim1, Diane M Simeone
1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA.
Current Opinion in Gastroenterology
|July 23, 2011
Summary
Targeting pancreatic cancer stroma shows promise for improving treatments. However, challenges remain in overcoming tumor heterogeneity and drug-resistant cancer stem cells.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- Pancreatic cancer features a dense, desmoplastic tumor stroma.
- Complex, supportive interactions exist between cancer cells and stromal components.
Purpose of the Study:
- To review recent studies on pancreatic cancer cell-stroma interactions.
- To explore therapeutic strategies targeting the tumor stroma.
Main Methods:
- Literature review of recent studies on pancreatic cancer stroma.
- Analysis of signaling pathways between cancer cells and cancer-associated fibroblasts.
- Evaluation of emerging therapeutic approaches targeting the stroma.
Main Results:
- Cancer-associated fibroblasts and signaling pathways contribute to hypoxic desmoplasia.
- Stromal targeting strategies show potential to enhance cytotoxic therapy efficacy.
- Tumor heterogeneity and cancer stem cells present significant challenges due to inherent resistance.
Conclusions:
- Targeting pancreatic cancer stroma is a justified novel therapeutic strategy.
- Further research is needed to develop effective therapies against resistant cancer cells.
